Recruiting
Systemic scleroderma+3
RecruitingStudy of AlloNK and rituximab with cyclophosphamide and fludarabine in adults with relapsing rheumatoid arthritis, inflammatory myopathies, systemic sclerosis, or Sjögren's disease
Registered drugNo placebo
Study of AlloNK and rituximab with cyclophosphamide and fludarabine in adults with relapsing rheumatoid arthritis, inflammatory myopathies, systemic sclerosis, or Sjögren's disease
Registered drugNo placebo
- Disease:Systemic sclerodermaRheumatoid arthritis+2
- Substances:CyclophosphamideRituximab+2
Countries:
Bulgaria
Bulgaria- Participants:18–64 years · 65+ years
- Substances:Cyclophosphamide
- Sponsor:Artiva Biotherapeutics Inc.
